Scribd Logo
Upload

Welcome to Scribd!

  • Proteomics - Technologies, Markets and Companies Part 2

    Uploaded by

    Peter Barfoot
    46 views1 page
    To purchase this report please return to: http://www.bioportfolio.net/report/3791-proteomics-technologies-markets-and-companies.html Proteomics is providing a better understanding of pathomechanisms of human diseases. Analysis of different levels of gene expression in healthy and diseased tissues by proteomic approaches is as important as the detection of mutations and polymorphisms at the genomic level and may be of more value in designing a rational therapy. Protein distribution / characterization in body tissues and fluids, in health as well as in disease, is the basis of the use of proteomic technologies for molecular diagnostics. Proteomics will play an important role in medicine of the future which will be personalized and will combine diagnostics with therapeutics. Important areas of application include cancer (oncoproteomics) and neurological disorders (neuroproteomics). The text is supplemented with 43 tables, 27 figures and over 500 selected references from the literature.

    Copyright

    © © All Rights Reserved

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    To purchase this report please return to: http://www.bioportfolio.net/report/3791-proteomics-technologies-markets-and-companies.html Proteomics is providing a better understanding of pathomechanisms of human diseases. Analysis of different levels of gene expression in healthy and diseased tissues by proteomic approaches is as important as the detection of mutations and polymorphisms at the genomic level and may be of more value in designing a rational therapy. Protein distribution / characterization in body tissues and fluids, in health as well as in disease, is the basis of the use of proteomic technologies for molecular diagnostics. Proteomics will play an important role in medicine of the future which will be personalized and will combine diagnostics with therapeutics. Important areas of application include cancer (oncoproteomics) and neurological disorders (neuroproteomics). The text is supplemented with 43 tables, 27 figures and over 500 selected references from the literature.

    Copyright:

    © All Rights Reserved
    Flag for inappropriate content
    46 views1 page

    Proteomics - Technologies, Markets and Companies Part 2

    Uploaded by

    Peter Barfoot
    To purchase this report please return to: http://www.bioportfolio.net/report/3791-proteomics-technologies-markets-and-companies.html Proteomics is providing a better understanding of pathomechanisms of human diseases. Analysis of different levels of gene expression in healthy and diseased tissues by proteomic approaches is as important as the detection of mutations and polymorphisms at the genomic level and may be of more value in designing a rational therapy. Protein distribution / characterization in body tissues and fluids, in health as well as in disease, is the basis of the use of proteomic technologies for molecular diagnostics. Proteomics will play an important role in medicine of the future which will be personalized and will combine diagnostics with therapeutics. Important areas of application include cancer (oncoproteomics) and neurological disorders (neuroproteomics). The text is supplemented with 43 tables, 27 figures and over 500 selected references from the literature.

    Copyright:

    © All Rights Reserved
    Flag for inappropriate content
    of 1

    TABLE

    11.

    OF

    CONTE NTS

    Companies involved in developing proteomics................................ 4

    Introduction....................................................................................................................4
    Profiles of selected companies ....................................................................................... 10
    Collaborations ............................................................................................................. 249

    Tables
    Table
    Table
    Table
    Table
    Table
    Table
    Table

    11-1:
    11-2:
    11-3:
    11-4:
    11-5:
    11-6:
    10-7:

    Companies with proteomics as the main activity/service................................................4


    Selected companies with equipment and laboratory services for proteomics......................6
    Biotechnology and drug discovery companies involved in proteomics ...............................6
    Bioinformatics companies involved in proteomics..........................................................8
    Biopharmaeutical companies with in-house proteomics technology ..................................9
    Major players in proteomics......................................................................................9
    Selected collaborations of companies in the area of proteomics....................................249

    -3-

    You might also like